Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 315

1.

Compartmentalization of anti-oxidant and anti-inflammatory gene expression in current and former smokers with COPD.

Sidhaye VK, Holbrook JT, Burke A, Sudini KR, Sethi S, Criner GJ, Fahey JW, Berenson CS, Jacobs MR, Thimmulappa R, Wise RA, Biswal S.

Respir Res. 2019 Aug 20;20(1):190. doi: 10.1186/s12931-019-1164-1.

2.

Mitochondrial dysfunction in human primary alveolar type II cells in emphysema.

Kosmider B, Lin CR, Karim L, Tomar D, Vlasenko L, Marchetti N, Bolla S, Madesh M, Criner GJ, Bahmed K.

EBioMedicine. 2019 Aug;46:305-316. doi: 10.1016/j.ebiom.2019.07.063. Epub 2019 Aug 2.

3.

Improving Lung Function in Severe Heterogenous Emphysema with the Spiration® Valve System (EMPROVE): A Multicenter, Open-Label, Randomized, Controlled Trial.

Criner GJ, Delage A, Voelker K, Hogarth DK, Majid A, Zgoda M, Lazarus DR, Casal R, Benzaquen SB, Holladay RC, Wellikoff A, Calero K, Rumbak MJ, Branca PR, Abu-Hijleh M, Mallea JM, Kalhan R, Sachdeva A, Kinsey CM, Lamb CR, Reed MF, Abouzgheib WB, Kaplan PV, Marrujo GX, Johnstone DW, Gasparri MG, Meade AA, Hergott CA, Reddy C, Mularski RA, Case AH, Makani SS, Shepherd RW, Chen B, Holt GE, Martel S; EMPROVE Study Group.

Am J Respir Crit Care Med. 2019 Jul 31. doi: 10.1164/rccm.201902-0383OC. [Epub ahead of print]

PMID:
31365298
4.

The relationship between DJ-1 and S100A8 in human primary alveolar type II cells in emphysema.

Lin CR, Bahmed K, Tomar D, Marchetti N, Criner GJ, Bolla S, Wilson MA, Madesh M, Kosmider B.

Am J Physiol Lung Cell Mol Physiol. 2019 Jul 17. doi: 10.1152/ajplung.00494.2018. [Epub ahead of print]

PMID:
31313618
5.

The role of DJ-1 in human primary alveolar type II cell injury induced by e-cigarette aerosol.

Bahmed K, Lin CR, Simborio H, Karim L, Aksoy M, Kelsen S, Tomar D, Madesh M, Elrod JW, Messier E, Mason RJ, Unterwald EM, Eisenstein TK, Criner GJ, Kosmider B.

Am J Physiol Lung Cell Mol Physiol. 2019 Jul 17. doi: 10.1152/ajplung.00567.2018. [Epub ahead of print]

PMID:
31313616
6.

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.

Pascoe S, Barnes N, Brusselle G, Compton C, Criner GJ, Dransfield MT, Halpin DMG, Han MK, Hartley B, Lange P, Lettis S, Lipson DA, Lomas DA, Martinez FJ, Papi A, Roche N, van der Valk RJP, Wise R, Singh D.

Lancet Respir Med. 2019 Jul 4. pii: S2213-2600(19)30190-0. doi: 10.1016/S2213-2600(19)30190-0. [Epub ahead of print]

PMID:
31281061
7.

It is time for the world to take COPD seriously: a statement from the GOLD board of directors.

Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, Vogelmeier CF, Chen R, Mortimer K, Montes de Oca M, Aisanov Z, Obaseki D, Decker R, Agusti A.

Eur Respir J. 2019 Jul 4;54(1). pii: 1900914. doi: 10.1183/13993003.00914-2019. Print 2019 Jul. No abstract available.

PMID:
31273036
8.

Benralizumab for the Prevention of COPD Exacerbations.

Criner GJ, Celli BR, Brightling CE, Agusti A, Papi A, Singh D, Sin DD, Vogelmeier CF, Sciurba FC, Bafadhel M, Backer V, Kato M, Ramírez-Venegas A, Wei YF, Bjermer L, Shih VH, Jison M, O'Quinn S, Makulova N, Newbold P, Goldman M, Martin UJ; GALATHEA and TERRANOVA Study Investigators.

N Engl J Med. 2019 May 20. doi: 10.1056/NEJMoa1905248. [Epub ahead of print]

PMID:
31112385
9.

The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.

Kim V, Zhao H, Regan E, Han MK, Make BJ, Crapo JD, Jones PW, Curtis JL, Silverman EK, Criner GJ; COPDGene Investigators.

Chest. 2019 May 15. pii: S0012-3692(19)30881-5. doi: 10.1016/j.chest.2019.03.041. [Epub ahead of print]

PMID:
31047955
10.

Automatic EPAP intelligent volume-assured pressure support is effective in patients with chronic respiratory failure: A randomized trial.

Orr JE, Coleman J, Criner GJ, Sundar KM, Tsai SC, Benjafield AV, Crocker ME, Willes L, Malhotra A, Owens RL, Wolfe LF.

Respirology. 2019 Apr 22. doi: 10.1111/resp.13546. [Epub ahead of print]

PMID:
31012225
11.

Chronic Obstructive Pulmonary Disease: Evaluation and Management.

Duffy SP, Criner GJ.

Med Clin North Am. 2019 May;103(3):453-461. doi: 10.1016/j.mcna.2018.12.005. Epub 2019 Mar 14. Review.

PMID:
30955513
12.

Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study.

Raghu G, Flaherty KR, Lederer DJ, Lynch DA, Colby TV, Myers JL, Groshong SD, Larsen BT, Chung JH, Steele MP, Benzaquen S, Calero K, Case AH, Criner GJ, Nathan SD, Rai NS, Ramaswamy M, Hagmeyer L, Davis JR, Gauhar UA, Pankratz DG, Choi Y, Huang J, Walsh PS, Neville H, Lofaro LR, Barth NM, Kennedy GC, Brown KK, Martinez FJ.

Lancet Respir Med. 2019 Jun;7(6):487-496. doi: 10.1016/S2213-2600(19)30059-1. Epub 2019 Apr 1.

PMID:
30948346
13.

Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.

Fortis S, Comellas A, Make BJ, Hersh CP, Bodduluri S, Georgopoulos D, Kim V, Criner GJ, Dransfield MT, Bhatt SP; COPDGene Investigators–Core Units: <italic>Administrative Center</italic>, COPDGene Investigators–Clinical Centers: <italic>Ann Arbor VA</italic>.

Ann Am Thorac Soc. 2019 Jul;16(7):826-835. doi: 10.1513/AnnalsATS.201809-601OC.

PMID:
30908927
14.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.

Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Criner GJ, Frith P, Halpin DMG, Han M, López Varela MV, Martinez F, Montes de Oca M, Papi A, Pavord ID, Roche N, Sin DD, Stockley R, Vestbo J, Wedzicha JA, Vogelmeier C.

Eur Respir J. 2019 May 18;53(5). pii: 1900164. doi: 10.1183/13993003.00164-2019. Print 2019 May. Review.

PMID:
30846476
15.

Endoscopic Lung Volume Reduction: An Expert Panel Recommendation - Update 2019.

Herth FJF, Slebos DJ, Criner GJ, Valipour A, Sciurba F, Shah PL.

Respiration. 2019;97(6):548-557. doi: 10.1159/000496122. Epub 2019 Mar 5.

PMID:
30836374
16.

Effect of daily azithromycin therapy and adherence on readmission risk in COPD.

Krishnan JK, Voelker H, Connett JE, Niewoehner DE, Albert RK, Scanlon PD, Criner GJ, Dransfield MT, Han MK, Martinez FJ; COPD Clinical Research Network Investigators.

Eur Respir J. 2019 Mar 18;53(3). pii: 1801377. doi: 10.1183/13993003.01377-2018. Print 2019 Mar. No abstract available.

PMID:
30819817
17.

Characteristics at the time of oxygen initiation associated with its adherence: Findings from the COPD Long-term Oxygen Treatment Trial.

Moy ML, Harrington KF, Sternberg AL, Krishnan JA, Albert RK, Au DH, Casaburi R, Criner GJ, Diaz P, Kanner RE, Panos RJ, Stibolt T, Stoller JK, Tonascia J, Yusen RD, Tan AM, Fuhlbrigge AL; LOTT Research Group.

Respir Med. 2019 Mar;149:52-58. doi: 10.1016/j.rmed.2019.02.004. Epub 2019 Feb 13.

PMID:
30803886
18.

Predictors of Response to Endobronchial Coil Therapy in Patients With Advanced Emphysema.

Slebos DJ, Cicenia J, Sciurba FC, Criner GJ, Hartman JE, Garner J, Deslée G, Delage A, Jantz M, Marquette CH, Strange C, Hatipoglu U, Mehta AC, LaPrad AS, Schmid-Bindert G, Herth FJF, Shah PL; RENEW Study Group.

Chest. 2019 May;155(5):928-937. doi: 10.1016/j.chest.2019.02.012. Epub 2019 Feb 21.

PMID:
30797746
19.

Non-Invasive Imaging Biomarker Identifies Small Airway Damage in Severe COPD.

Vasilescu DM, Martinez FJ, Marchetti N, Galbán CJ, Hatt C, Meldrum CA, Dass C, Tanabe N, Reddy RM, Lagstein A, Ross BD, Labaki WW, Murray S, Xia M, Curtis JL, Hackett TL, Kazerooni EA, Criner GJ, Hogg JC, Han MK.

Am J Respir Crit Care Med. 2019 Feb 22. doi: 10.1164/rccm.201811-2083OC. [Epub ahead of print]

PMID:
30794432
20.

Effects of Roflumilast on Rehospitalization and Mortality in Patients.

Criner GJ, Jacobs MR, Zhao H, Marchetti N.

Chronic Obstr Pulm Dis. 2018 Dec 20;6(1):74-85. doi: 10.15326/jcopdf.6.1.2018.0139.

21.

Patient Preferences for Endobronchial Valve Treatment of Severe Emphysema.

Mansfield C, Sutphin J, Shriner K, Criner GJ, Celli BR.

Chronic Obstr Pulm Dis. 2018 Dec 11;6(1):51-63. doi: 10.15326/jcopdf.6.1.2018.0147.

22.

Effect of Lung Volume Reduction Surgery on Respiratory Muscle Strength in Advanced Emphysema.

Criner RN, Yu D, Jacobs MR, Criner GJ.

Chronic Obstr Pulm Dis. 2018 Oct 12;6(1):40-50. doi: 10.15326/jcopdf.6.1.2018.0188.

23.

Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study.

Papi A, Zheng J, Criner GJ, Fabbri LM, Calverley PMA.

Respir Med. 2019 Feb;147:37-43. doi: 10.1016/j.rmed.2018.12.014. Epub 2019 Jan 9.

PMID:
30704697
24.

Impaired non-homologous end joining in human primary alveolar type II cells in emphysema.

Kosmider B, Lin CR, Vlasenko L, Marchetti N, Bolla S, Criner GJ, Messier E, Reisdorph N, Powell RL, Madesh M, Kelsen S, Xander N, Correll KA, Mason RJ, Bahmed K.

Sci Rep. 2019 Jan 29;9(1):920. doi: 10.1038/s41598-018-37000-z.

25.

Temporary transvenous diaphragm pacing vs. standard of care for weaning from mechanical ventilation: study protocol for a randomized trial.

Evans D, Shure D, Clark L, Criner GJ, Dres M, de Abreu MG, Laghi F, McDonagh D, Petrof B, Nelson T, Similowski T.

Trials. 2019 Jan 17;20(1):60. doi: 10.1186/s13063-018-3171-9.

26.

Using the Peripheral Blood Eosinophil Count to Manage Patients with Chronic Obstructive Pulmonary Disease.

Celli BR, Criner GJ.

Ann Am Thorac Soc. 2019 Mar;16(3):301-303. doi: 10.1513/AnnalsATS.201810-729PS. No abstract available.

PMID:
30620613
27.

Race and Gender Disparities are Evident in COPD Underdiagnoses Across all Severities of Measured Airflow Obstruction.

Mamary AJ, Stewart JI, Kinney GL, Hokanson JE, Shenoy K, Dransfield MT, Foreman MG, Vance GB, Criner GJ; COPDGene® Investigators.

Chronic Obstr Pulm Dis. 2018 Jul 2;5(3):177-184. doi: 10.15326/jcopdf.5.3.2017.0145.

28.

Clinical Differences in COPD Patients with Variable Patterns of Hypoxemia.

Narewski ER, Blackford AL, Lammi MR, Fuhlbrigge AL, Soler X, Albert R, Criner GJ; Long-Term Oxygen Treatment Trial Research Group.

Chronic Obstr Pulm Dis. 2018 Apr 28;5(3):167-176. doi: 10.15326/jcopdf.5.3.2017.0175.

29.

Let's Call It Lung Shock - Or Do We Use the Right Wording?

Herth FJF, Sorichter S, Criner GJ.

Respiration. 2019;97(3):197-198. doi: 10.1159/000495256. Epub 2018 Dec 12. No abstract available.

PMID:
30540992
30.

Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee.

Criner GJ, Martinez FJ, Aaron S, Agusti A, Anzueto A, Bafadhel M, Barnes PJ, Bourbeau J, Chen R, Ewig J, Fabbri LM, Frith P, Halpin DMG, Han M, Montes de Oca M, Nishimura M, O'Donnell D, Papi A, Pavord I, Roche N, Rodriguez-Roisin R, Salvi S, Singh D, Sin DD, Stockley R, López Varela MV, Vestbo J, Vogelmeier CF, Washko G, Wedzicha JA, Celli BR.

Ann Am Thorac Soc. 2019 Jan;16(1):29-39. doi: 10.1513/AnnalsATS.201808-557PS. No abstract available.

PMID:
30427736
31.

Inflammatory signature in lung tissues in patients with combined pulmonary fibrosis and emphysema.

Cornwell WD, Kim C, Lastra AC, Dass C, Bolla S, Wang H, Zhao H, Ramsey FV, Marchetti N, Rogers TJ, Criner GJ.

Biomarkers. 2019 May;24(3):232-239. doi: 10.1080/1354750X.2018.1542458. Epub 2018 Nov 19.

PMID:
30411980
32.

Markers of Dental Health Correlate with Daily Respiratory Symptoms in COPD.

Gaeckle NT, Heyman B, Criner AJ, Criner GJ.

Chronic Obstr Pulm Dis. 2018 Apr 1;5(2):97-105. doi: 10.15326/jcopdf.5.2.2017.0159.

33.

Endobronchial Coils Versus Lung Volume Reduction Surgery or Medical Therapy for Treatment of Advanced Homogenous Emphysema.

Marchetti N, Kaufman T, Chandra D, Herth FJ, Shah PL, Slebos DJ, Dass C, Bicknell S, Blaas SH, Pfeifer M, Stanzell F, Witt C, Deslee G, Gesierich W, Hetzel M, Kessler R, Leroy S, Hetzel J, Sciurba FC, Criner GJ.

Chronic Obstr Pulm Dis. 2018 Apr 1;5(2):87-96. doi: 10.15326/jcopdf.5.2.2017.0134.

34.

Genomics and response to long-term oxygen therapy in chronic obstructive pulmonary disease.

Seo M, Qiu W, Bailey W, Criner GJ, Dransfield MT, Fuhlbrigge AL, Reilly JJ, Scholand MB, Castaldi P, Chase R, Parker M, Saferali A, Yun JH, Crapo JD, Cho MH, Beaty TH, Silverman EK, Hersh CP.

J Mol Med (Berl). 2018 Dec;96(12):1375-1385. doi: 10.1007/s00109-018-1708-8. Epub 2018 Oct 23.

PMID:
30353303
35.

Failure of Low-Dose Theophylline to Prevent Exacerbations in Patients With COPD.

Criner GJ, Celli BR.

JAMA. 2018 Oct 16;320(15):1541-1542. doi: 10.1001/jama.2018.14295. No abstract available.

PMID:
30326108
36.

S100A8 Protects Human Primary Alveolar Type II Cells against Injury and Emphysema.

Lin CR, Bahmed K, Criner GJ, Marchetti N, Tuder RM, Kelsen S, Bolla S, Mandapati C, Kosmider B.

Am J Respir Cell Mol Biol. 2019 Mar;60(3):299-307. doi: 10.1165/rcmb.2018-0144OC.

PMID:
30277795
37.

Reply to: The LIBERATE trial: Options to Reduce the Risk of Post-Procedural Pneumothorax and Length of Stay.

Criner GJ, Sue R, Sciurba FC, Slebos DJ.

Am J Respir Crit Care Med. 2018 Sep 19. doi: 10.1164/rccm.201808-1477LE. [Epub ahead of print] No abstract available.

PMID:
30230349
38.

Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS.

Ghosh S, Anderson WH, Putcha N, Han MK, Curtis JL, Criner GJ, Dransfield MT, Barr RG, Krishnan JA, Lazarus SC, Cooper CB, Paine R 3rd, Peters SP, Hansel NN, Martinez FJ, Drummond MB; Current and former investigators of the SPIROMICS sites and reading centers.

Ann Am Thorac Soc. 2019 Feb;16(2):200-208. doi: 10.1513/AnnalsATS.201804-283OC.

PMID:
30216731
39.

Lung volume reduction surgery or bronchoscopic lung volume reduction: is there an algorithm for allocation?

Gordon M, Duffy S, Criner GJ.

J Thorac Dis. 2018 Aug;10(Suppl 23):S2816-S2823. doi: 10.21037/jtd.2018.05.118. Review.

40.

Single-Inhaler Triple versus Dual Therapy in Patients with COPD.

Lipson DA, Criner GJ, Lomas DA.

N Engl J Med. 2018 Aug 9;379(6):592-593. doi: 10.1056/NEJMc1807380. No abstract available.

PMID:
30089077
41.

Seasonal and Regional Variations in Chronic Obstructive Pulmonary Disease Exacerbation Rates in Adults without Cardiovascular Risk Factors.

So JY, Zhao H, Voelker H, Reed RM, Sin D, Marchetti N, Criner GJ.

Ann Am Thorac Soc. 2018 Nov;15(11):1296-1303. doi: 10.1513/AnnalsATS.201801-070OC.

PMID:
30063372
42.

Relationship of Absolute Telomere Length With Quality of Life, Exacerbations, and Mortality in COPD.

Jin M, Lee EC, Ra SW, Fishbane N, Tam S, Criner GJ, Woodruff PG, Lazarus SC, Albert R, Connett JE, Han MK, Martinez FJ, Aaron SD, Reed RM, Man SFP, Leung JM, Sin DD.

Chest. 2018 Aug;154(2):266-273. doi: 10.1016/j.chest.2018.05.022. Epub 2018 Jul 12.

PMID:
30017346
43.

Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome.

Dotan Y, Vaidy A, Shapiro WB, Zhao H, Dass C, Toyoda Y, Marchetti N, Shenoy K, Cordova FC, Criner GJ, Mamary AJ.

Chest. 2018 Oct;154(4):818-826. doi: 10.1016/j.chest.2018.06.027. Epub 2018 Jun 30.

PMID:
29966665
44.

Activation and polarization of circulating monocytes in severe chronic obstructive pulmonary disease.

Cornwell WD, Kim V, Fan X, Vega ME, Ramsey FV, Criner GJ, Rogers TJ.

BMC Pulm Med. 2018 Jun 15;18(1):101. doi: 10.1186/s12890-018-0664-y.

45.

COPD Home Oxygen Therapy and Home Mechanical Ventilation: Improving Admission-Free Survival in Persistent Hypercapnic COPD.

Criner GJ, Dreher M, Hart N, Murphy P.

Chest. 2018 Jun;153(6):1499-1500. doi: 10.1016/j.chest.2018.03.053.

PMID:
29884255
46.

COPD Advanced Patient Management.

Criner GJ, Dreher M, D'Ambrosio CM, Zuwallack R, Geiseler J, Pépin JL.

Chest. 2018 Jun;153(6):1497-1498. doi: 10.1016/j.chest.2018.03.054.

PMID:
29884254
47.

A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE).

Criner GJ, Sue R, Wright S, Dransfield M, Rivas-Perez H, Wiese T, Sciurba FC, Shah PL, Wahidi MM, de Oliveira HG, Morrissey B, Cardoso PFG, Hays S, Majid A, Pastis N Jr, Kopas L, Vollenweider M, McFadden PM, Machuzak M, Hsia DW, Sung A, Jarad N, Kornaszewska M, Hazelrigg S, Krishna G, Armstrong B, Shargill NS, Slebos DJ; LIBERATE Study Group.

Am J Respir Crit Care Med. 2018 Nov 1;198(9):1151-1164. doi: 10.1164/rccm.201803-0590OC.

48.

Impact of Comorbidities on the Treatment of Chronic Obstructive Pulmonary Disease.

Garvey C, Criner GJ.

Am J Med. 2018 Sep;131(9S):23-29. doi: 10.1016/j.amjmed.2018.05.002. Epub 2018 May 17.

PMID:
29777661
49.

Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses.

Halpin DMG, Birk R, Brealey N, Criner GJ, Dransfield MT, Hilton E, Lomas DA, Zhu CQ, Lipson DA.

ERJ Open Res. 2018 May 4;4(2). pii: 00119-2017. doi: 10.1183/23120541.00119-2017. eCollection 2018 Apr.

50.

Efficacy and safety profile of xanthines in COPD: a network meta-analysis.

Cazzola M, Calzetta L, Barnes PJ, Criner GJ, Martinez FJ, Papi A, Gabriella Matera M.

Eur Respir Rev. 2018 May 2;27(148). pii: 180010. doi: 10.1183/16000617.0010-2018. Print 2018 Jun 30. Review.

Supplemental Content

Loading ...
Support Center